Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0L9PF
|
||||
| Former ID |
DNC012317
|
||||
| Drug Name |
LY-73497
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Discontinued in Phase 1 | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C12H13N3S2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCNC(=S)NC2=NC=CS2
|
||||
| InChI |
1S/C12H13N3S2/c16-11(15-12-14-8-9-17-12)13-7-6-10-4-2-1-3-5-10/h1-5,8-9H,6-7H2,(H2,13,14,15,16)
|
||||
| InChIKey |
ANUSGJXVCFPWMQ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | HIV-1 reverse transcriptase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002844) | ||||
| REF 2 | J Med Chem. 1995 Dec 8;38(25):4929-36.Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studiesof PETT analogs. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.